AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
AtriCure, Inc.
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SD43V3
58.97▼ 0.33 (-0.56%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
59.30
Day's Range
58.53 – 59.56
52-Week Range
25.36 – 61.70
Volume
489.1K
Avg Volume
1.2M
Share Statistics
Shares Outstanding
Employees
1,350
Exchange
XNAS
Listed
2005-08-05
Share count as of July 22, 2026

AtriCure, Inc. (ATRC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about AtriCure, Inc. (ATRC)
What is AtriCure, Inc.'s Market Cap?
AtriCure, Inc.'s Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Enterprise Value?
AtriCure, Inc.'s Enterprise Value is $2.9B, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Trailing P/E?
AtriCure, Inc.'s Trailing P/E is 284.3×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Price / Sales?
AtriCure, Inc.'s Price / Sales is 5.3×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s EV / Revenue?
AtriCure, Inc.'s EV / Revenue is 5.1×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s EV / EBITDA?
AtriCure, Inc.'s EV / EBITDA is 85.9×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Revenue (TTM)?
AtriCure, Inc.'s Revenue (TTM) is $569.6M, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Net Income (TTM)?
AtriCure, Inc.'s Net Income (TTM) is $10.6M, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s EBITDA?
AtriCure, Inc.'s EBITDA is $33.7M, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Diluted EPS (TTM)?
AtriCure, Inc.'s Diluted EPS (TTM) is 0.21, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ATRCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+12.8%+14.3%+13.1%+15.8%
Cost of revenue
Gross profit
% of revenue77.2%77.4%75.0%75.5%
Operating expenses:
Research and development expenses
Selling, general and administrative expenses
Total operating expenses
% of revenue70.9%77.0%73.2%75.3%
Income (loss) from operations
% of revenue6.3%0.4%1.8%0.2%
Other income (expense):
Interest expense
Interest income
Other income (expense)
Income (loss) before income tax expense
Income tax expense
Net income (loss)
% of revenue5.8%0.1%1.2%-0.2%
Basic net income (loss) per share (in usd per share)
Diluted net income (loss) per share (in usd per share)